Daichi Fujimoto, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Plaque, Atherosclerotic | 13 | 2024 | 1530 | 1.630 |
Why?
|
Coronary Artery Disease | 16 | 2024 | 6395 | 1.230 |
Why?
|
Coronary Vessels | 15 | 2024 | 3096 | 1.090 |
Why?
|
Tomography, Optical Coherence | 16 | 2024 | 2917 | 0.910 |
Why?
|
Coronary Angiography | 16 | 2024 | 4472 | 0.860 |
Why?
|
Acute Coronary Syndrome | 7 | 2024 | 2190 | 0.640 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2024 | 754 | 0.590 |
Why?
|
Brain Infarction | 1 | 2018 | 290 | 0.540 |
Why?
|
Pneumocystis carinii | 1 | 2014 | 72 | 0.440 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1313 | 0.420 |
Why?
|
Catheter Ablation | 2 | 2022 | 2752 | 0.380 |
Why?
|
Predictive Value of Tests | 7 | 2024 | 15262 | 0.350 |
Why?
|
Rupture, Spontaneous | 3 | 2024 | 362 | 0.330 |
Why?
|
Pneumonia | 1 | 2021 | 2140 | 0.330 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2022 | 322 | 0.310 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2018 | 2223 | 0.260 |
Why?
|
Retrospective Studies | 19 | 2024 | 80582 | 0.250 |
Why?
|
Venous Thromboembolism | 1 | 2018 | 1866 | 0.250 |
Why?
|
Adipose Tissue | 3 | 2024 | 3312 | 0.230 |
Why?
|
Mammary Arteries | 1 | 2024 | 81 | 0.230 |
Why?
|
Atherectomy, Coronary | 1 | 2023 | 142 | 0.210 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5302 | 0.200 |
Why?
|
Serpins | 1 | 2024 | 247 | 0.200 |
Why?
|
Neutrophils | 1 | 2014 | 3766 | 0.190 |
Why?
|
Heart Septum | 1 | 2022 | 303 | 0.190 |
Why?
|
Treatment Outcome | 11 | 2024 | 64651 | 0.180 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11740 | 0.170 |
Why?
|
Chemokines | 1 | 2024 | 959 | 0.170 |
Why?
|
Risk Factors | 8 | 2024 | 74167 | 0.170 |
Why?
|
Lipids | 3 | 2024 | 3340 | 0.150 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 675 | 0.140 |
Why?
|
Angioplasty, Balloon | 1 | 2021 | 588 | 0.140 |
Why?
|
Drug-Eluting Stents | 1 | 2023 | 681 | 0.140 |
Why?
|
Japan | 1 | 2021 | 1371 | 0.140 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13337 | 0.140 |
Why?
|
Coronary Stenosis | 1 | 2022 | 794 | 0.130 |
Why?
|
Aged | 14 | 2024 | 169235 | 0.130 |
Why?
|
Lung Diseases, Interstitial | 1 | 2024 | 917 | 0.130 |
Why?
|
Cholesterol, HDL | 1 | 2022 | 1814 | 0.120 |
Why?
|
Coronary Artery Bypass | 1 | 2023 | 2189 | 0.110 |
Why?
|
Humans | 27 | 2024 | 761423 | 0.110 |
Why?
|
Cryosurgery | 1 | 2018 | 474 | 0.110 |
Why?
|
Video Recording | 1 | 2018 | 966 | 0.110 |
Why?
|
Heart Conduction System | 1 | 2018 | 1010 | 0.100 |
Why?
|
Cholesterol | 1 | 2022 | 2902 | 0.100 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2014 | 242 | 0.100 |
Why?
|
Pulmonary Veins | 1 | 2018 | 746 | 0.100 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15838 | 0.100 |
Why?
|
Middle Aged | 12 | 2024 | 220826 | 0.100 |
Why?
|
Male | 14 | 2024 | 360736 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 1007 | 0.090 |
Why?
|
Positive-Pressure Respiration | 1 | 2014 | 639 | 0.090 |
Why?
|
Echocardiography | 1 | 2022 | 4991 | 0.080 |
Why?
|
Cytokines | 1 | 2024 | 7392 | 0.080 |
Why?
|
Prognosis | 5 | 2024 | 29620 | 0.080 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5840 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2024 | 3407 | 0.070 |
Why?
|
Female | 13 | 2024 | 392581 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13502 | 0.070 |
Why?
|
Phenotype | 1 | 2024 | 16606 | 0.070 |
Why?
|
Registries | 1 | 2022 | 8223 | 0.070 |
Why?
|
Chemokine CCL11 | 1 | 2024 | 128 | 0.060 |
Why?
|
Inflammation | 4 | 2024 | 10762 | 0.060 |
Why?
|
Risk Assessment | 2 | 2024 | 23990 | 0.050 |
Why?
|
Time Factors | 2 | 2024 | 39975 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2024 | 11458 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 21341 | 0.050 |
Why?
|
Chemokine CCL2 | 1 | 2024 | 605 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2024 | 695 | 0.050 |
Why?
|
Prospective Studies | 2 | 2023 | 54415 | 0.050 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2024 | 891 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39117 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2014 | 5291 | 0.040 |
Why?
|
Survival Rate | 1 | 2014 | 12720 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 5127 | 0.040 |
Why?
|
Popliteal Artery | 1 | 2021 | 310 | 0.040 |
Why?
|
Angioplasty | 1 | 2021 | 354 | 0.040 |
Why?
|
Air | 1 | 2018 | 187 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1097 | 0.040 |
Why?
|
Fibrosis | 1 | 2024 | 2048 | 0.030 |
Why?
|
Placenta | 1 | 2024 | 1708 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3207 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2021 | 1495 | 0.030 |
Why?
|
Heart Atria | 1 | 2018 | 1347 | 0.030 |
Why?
|
Heart | 1 | 2024 | 4405 | 0.020 |
Why?
|
Equipment Design | 1 | 2018 | 3509 | 0.020 |
Why?
|
Proteomics | 1 | 2024 | 3845 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9320 | 0.020 |
Why?
|
Pregnancy | 1 | 2024 | 29862 | 0.010 |
Why?
|
Adult | 1 | 2014 | 221148 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58956 | 0.010 |
Why?
|